<table id="_RefID0EDQAG" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 4. The Effect of CRESEMBA on the Pharmacokinetics of Other Drugs</caption>
<col width="20%"></col>
<col width="26%"></col>
<col width="54%"></col>
<tfoot>
<tr>
<td align="left" colspan="6" stylecode="Botrule" valign="top">
<sup>a </sup>400 mg of lopinavir in combination with 100 mg of ritonavir.</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top"></td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Recommendation</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Comments</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Lopinavir/ritonavir<sup>a</sup>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Use with Caution</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Concomitant administration of lopinavir/ritonavir and CRESEMBA resulted in decreased exposure of lopinavir and ritonavir that could possibly result in loss of antiviral efficacy <content stylecode="italics">[see <linkhtml href="#ID_4df688e1-3372-46f1-84fe-26bb9c068e2e">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_99c5510a-23ee-483b-a9aa-cb3f925d04cd">12.3</linkhtml>)]</content>.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Atorvastatin</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Use with Caution </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Caution should be used when atorvastatin is used with CRESEMBA due to a potential increase in atorvastatin exposure. Monitor patients for adverse reactions that are typical of atorvastatin.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Cyclosporine</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Use with Caution</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Concomitant administration of CRESEMBA and cyclosporine results in increase in cyclosporine exposure. Monitor drug concentrations of cyclosporine and adjust dose as needed <br/>
<content stylecode="italics">[see <linkhtml href="#ID_4df688e1-3372-46f1-84fe-26bb9c068e2e">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_99c5510a-23ee-483b-a9aa-cb3f925d04cd">12.3</linkhtml>)]</content>.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Sirolimus</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Use with Caution</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Concomitant administration of CRESEMBA and sirolimus results in increase in sirolimus exposure. Monitor drug concentrations of sirolimus and adjust dose as needed <br/>
<content stylecode="italics">[see <linkhtml href="#ID_4df688e1-3372-46f1-84fe-26bb9c068e2e">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_99c5510a-23ee-483b-a9aa-cb3f925d04cd">12.3</linkhtml>)]</content>.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Tacrolimus</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Use with Caution</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Concomitant administration of CRESEMBA and tacrolimus results in increase in tacrolimus exposure. Monitor drug concentrations of tacrolimus and adjust dose as needed <br/>
<content stylecode="italics">[see <linkhtml href="#ID_4df688e1-3372-46f1-84fe-26bb9c068e2e">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_99c5510a-23ee-483b-a9aa-cb3f925d04cd">12.3</linkhtml>)]</content>.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Midazolam</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Use with Caution</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Concomitant administration of CRESEMBA and midazolam results in increase in midazolam exposure. Consider dose reduction of midazolam when isavuconazole is coadministered <content stylecode="italics">[see <linkhtml href="#ID_4df688e1-3372-46f1-84fe-26bb9c068e2e">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_99c5510a-23ee-483b-a9aa-cb3f925d04cd">12.3</linkhtml>)]</content>.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Bupropion</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Use with Caution</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Concomitant administration of CRESEMBA and bupropion results in decrease in bupropion exposure. Dose increase of bupropion may be necessary when coadministered with CRESEMBA, but should not exceed the maximum recommended dose <content stylecode="italics">[see <linkhtml href="#ID_4df688e1-3372-46f1-84fe-26bb9c068e2e">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_99c5510a-23ee-483b-a9aa-cb3f925d04cd">12.3</linkhtml>)]</content>.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Mycophenolate Mofetil</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Use with Caution</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Concomitant administration of CRESEMBA and MMF results in increase in MMF exposure. Patients receiving CRESEMBA concurrently with MMF should be monitored for MPA-related toxicities <content stylecode="italics">[see <linkhtml href="#ID_4df688e1-3372-46f1-84fe-26bb9c068e2e">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_99c5510a-23ee-483b-a9aa-cb3f925d04cd">12.3</linkhtml>)]</content>.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>Digoxin</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>Use with Caution</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>Concomitant administration of CRESEMBA and digoxin results in increase in digoxin exposure. Serum digoxin concentrations should be monitored and used for titration when dosed concurrently with CRESEMBA <br/>
<content stylecode="italics">[see <linkhtml href="#ID_4df688e1-3372-46f1-84fe-26bb9c068e2e">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_99c5510a-23ee-483b-a9aa-cb3f925d04cd">12.3</linkhtml>)]</content>.</paragraph>
</td>
</tr>
</tbody>
</table>